Teleflex Incorporated (NYSE:TFX) Shares Bought by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 5.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 108,231 shares of the medical technology company's stock after purchasing an additional 5,322 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.23% of Teleflex worth $19,263,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Confluence Wealth Services Inc. lifted its position in Teleflex by 39.6% during the fourth quarter. Confluence Wealth Services Inc. now owns 1,410 shares of the medical technology company's stock valued at $255,000 after purchasing an additional 400 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its position in Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company's stock valued at $1,053,000 after purchasing an additional 1,527 shares during the period. Hager Investment Management Services LLC acquired a new position in Teleflex during the fourth quarter valued at $77,000. Boston Trust Walden Corp increased its holdings in Teleflex by 3.9% in the fourth quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company's stock valued at $52,435,000 after buying an additional 11,052 shares in the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its holdings in Teleflex by 48.3% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 2,250 shares of the medical technology company's stock valued at $400,000 after buying an additional 733 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Truist Financial cut their price objective on shares of Teleflex from $227.00 to $200.00 and set a "hold" rating for the company in a report on Wednesday, December 18th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a report on Monday, December 16th. Mizuho cut their price objective on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, November 1st. StockNews.com raised shares of Teleflex from a "hold" rating to a "buy" rating in a report on Thursday, November 28th. Finally, Royal Bank of Canada cut their price objective on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $252.50.

Teleflex Price Performance

Shares of TFX stock traded down $0.17 on Friday, reaching $167.44. 518,347 shares of the company were exchanged, compared to its average volume of 521,420. The company has a market cap of $7.78 billion, a price-to-earnings ratio of 33.29, a P/E/G ratio of 1.72 and a beta of 1.16. The business has a 50-day moving average price of $178.15 and a 200 day moving average price of $209.23. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 1 year low of $166.76 and a 1 year high of $256.85.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.